Physician
Raul I Vila MD & Associates PA
Raul I Vila MD & Associates PA was paid $114K by Medicaid between Jan 2018 and Nov 2024, across 37 billing codes. Its largest line is 87635, Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe — 29% of everything it billed.
33Billing provider infoRAUL I VILA MD & ASSOCIATES PA
MIAMI, FL 33155
MIAMI, FL 33155
33aNPI1073653291assigned 02/07/2007
33bProvider typeAnatomic Pathology & Clinical Pathology Physician
28Total paid$114K
24GClaims47,124
24DCodes billed37
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Anatomic Pathology & Clinical Pathology Physician providers in Florida
Rank by total paid#75 of 207
Median peer was paid$39K
This provider vs. median2.9×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 2,162 | $2K | |
| 2019 | 11,556 | $21K | |
| 2020 | 7,208 | $23K | |
| 2021 | 11,069 | $47K | |
| 2022 | 2,105 | $6K | |
| 2023 | 6,484 | $10K | |
| 2024incomplete | 6,540 | $5K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 29% | 1,621 | 1,038 | $33K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 26% | 1,155 | 911 | $30K |
| 84702 | 7.0% | 374 | 319 | $8K | |
| 80320 | 5.6% | 739 | 511 | $6K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 5.4% | 7,927 | 3,104 | $6K |
| 80053 | Comprehensive metabolic panel | 3.7% | 1,908 | 1,246 | $4K |
| 81025 | 3.2% | 1,085 | 863 | $4K | |
| 85060 | 3.1% | 671 | 465 | $4K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 3.1% | 8,876 | 3,675 | $4K |
| 82962 | 2.6% | 6,971 | 637 | $3K | |
| 82550 | 2.3% | 2,700 | 1,485 | $3K | |
| 88342 | 1.7% | 136 | 108 | $2K |
25 more codes
| 85027 | 1.5% | 525 | $2K | |
| 84484 | 1.4% | 1,895 | $2K | |
| 81001 | <1% | 3,442 | $841.02 | |
| 82553 | <1% | 1,234 | $589.47 | |
| 83540 | <1% | 12 | $342.91 | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 141 | $303.79 |
| 83690 | <1% | 690 | $280.87 | |
| 85730 | <1% | 952 | $274.46 | |
| 85610 | <1% | 1,381 | $252.28 | |
| 80076 | <1% | 47 | $217.35 | |
| 82948 | <1% | 644 | $213.00 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 95 | $200.85 |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 125 | $167.40 |
| 80305 | <1% | 658 | $138.93 | |
| 87400 | <1% | 43 | $123.09 | |
| 83605 | <1% | 108 | $122.60 | |
| 82150 | <1% | 75 | $108.57 | |
| 80164 | <1% | 197 | $102.34 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 109 | $81.35 |
| 85007 | <1% | 407 | $69.96 | |
| 82140 | <1% | 102 | $24.26 | |
| 82728 | <1% | 34 | $15.89 | |
| 86140 | <1% | 21 | $4.05 | |
| 83550 | <1% | 12 | $1.38 | |
| 83615 | <1% | 12 | $0.81 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialVILA, RAUL (PRESIDENT)